BTO_0001948
stringlengths
11
11
JURKAT E-6.1 cell
stringlengths
2
47
Human, blood, leukemia, T cell line, clone E6.1.
stringlengths
20
1.28k
EFO_0022576
EC-9706
Human esophageal carcinoma cell line
EFO_0022577
D-270MG
Human glioblastoma cell line
EFO_0022578
G-292
Human osteosarcoma cell line
EFO_0022580
BL-41
Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma
EFO_0022583
SNU-251
Human ovarian endometrial cancer cell line
EFO_0022584
SACC-LM
Human salivary gland adenoid cystic carcinoma cell line
EFO_0022586
M249
Human melanoma cell line BRAF V600E mutation
EFO_0022587
HKB-11
Human somatic cell hybridoma (fused human embryonic kidney cells (293S) and modified Burkitt's lymphoma cells (2B8))
EFO_0022588
EUFA143
Human Fanconi anemia cell line
EFO_0022589
EUFA121
Human Fanconi anemia cell line
EFO_0022592
CAL-33
Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy).
EFO_0022593
YTS-Eco
Human NK cell lymphoblastic leukemia/lymphoma cell line
EFO_0022594
HCN-1A
Human cortical neuronal cell line, established from a 18 months old female patient that suffered from unilateral megalencephaly.
EFO_0022595
PNT2
Human normal prostate epithelium cell line immortalized with SV40.
EFO_0022616
BD-215
Human Fanconi anemia cell line
EFO_0022617
MM200
Human melanoma cell line
EFO_0022618
MGR3
Human glioblastoma cell line
EFO_0022619
Rh-28
Human alveolar rhabdomyosarcoma cell line
EFO_0022620
CFBE41o-
Human Cystic fibrotic bronchial epithelial cell line
EFO_0022621
OECM-1
Human oral squamous cell carcinoma cell line
EFO_0022622
LCL 721.221
Human lymphoblastoid cell line
EFO_0022623
SOSP-9607
Human osteosarcoma cell line
EFO_0022625
ST-1
Human adult T cell lymphoma cell line
EFO_0022626
C666
Human nasopharyngeal carcinoma cell line
EFO_0022627
U-178MG
Human astrocytoma cell line
EFO_0022629
TPC-1
Human papillary thyroid carcinoma cell line
EFO_0022630
AC16
Human hybrid cardiomyocyte
EFO_0022632
2BS
Human transformed human fetal lung cell line
EFO_0022633
IHCF
Human immortalized corneal fibroblast
EFO_0022634
H157
Human oral squamous cell carcinoma cell line
EFO_0022635
PRIESS
EBV-transformed human lymphoblastoid cell line
EFO_0022636
FET
Human colorectal cancer cell line
EFO_0022637
T47D:A18
Human invasive breast carcinoma
EFO_0022638
SK-UT-2
Human endometrial carcinoma cell line
EFO_0022639
MO3.13
Human hybrid cell line that express phenotypic characteristics of primary oligodendrocytes
EFO_0022640
SAVC
Human B-lymphoblastoid cell line
EFO_0022641
BM9
Human B-lymphoblastoid cell line
EFO_0022642
PLH
Human B-lymphoblastoid cell line
EFO_0022643
BON-1
Human pancreatic neuroendocrine tumor cell line
EFO_0022644
PH5CH8
Human hepatocyte cell line
EFO_0022645
CWR-R1
Human prostate carcinoma cell line
EFO_0022646
HER911
Human embryonic retinoblasts
EFO_0022647
C-28/I2
Immortalized human chondrocyte cell line
EFO_0022648
253J-BV
Highly metastatic variant from human transitional cell carcinoma
EFO_0022649
KHYG-1
Human natural killer cell leukemia
EFO_0022650
UPCI-SCC-131
Human oral squamous cell carcinoma cell line
EFO_0022651
IHKE-1
Human immortalized kidney epithelial cell line
EFO_0022652
C3ABR
Human lymphoblastoid cell line
EFO_0022653
Hs-578Bst
Human breast epithelial cell line
EFO_0022654
MLS 2645-94
Human myxoid liposarcoma cell line
EFO_0022655
MLS 402-91
Human myxoid liposarcoma cell line
EFO_0022657
HOM-2
Human B-lymphoblastoid cell line
EFO_0022658
TE-1
Human esophageal squamous cell carcinoma cell line
EFO_0022659
EoL-1
Human eosinophilic leukaemia cell line
EFO_0022660
PITOUT
Human lymphoblastoid cell line
EFO_0022661
LCL1
Human lymphoblastoid cell line
EFO_0022662
OSU-2
Human fibroblast cell line
EFO_0022663
HuH-7-Lunet
Human hepatocellular carcinoma cell line
EFO_0022664
Colo-320
Human colorectal cancer cell line
EFO_0022665
SF-188
Human glioma cell line
EFO_0022667
RCB2099
immortal human esophagus-derived cell line
EFO_0022668
OVCAR-10
Human ovarian carcinoma cell line
EFO_0022669
8505C
Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma
EFO_0022670
UWR1
Human anaplastic astrocytoma cell line
EFO_0022671
UWR2
Human glioblastoma cell line
EFO_0022672
GES-1
Human normal gastric epithelial cell line
EFO_0022673
BHP5-16
Human amelanotic melanoma cell line
EFO_0022674
K1
Human thyroid gland papillary carcinoma cell line
EFO_0022675
NCI-H3122
immortal human lung-derived cell line
EFO_0022676
SW-1736
Human anaplastic thyroid cancer cell line
EFO_0022677
5-8F
High tumorigenic and metastatic subline of SUNE-1 cell line
EFO_0022678
HCCLM-3
Human hepatocellular carcinoma cell line
EFO_0022679
SACC-83
Human salivary gland adenoid cystic carcinoma
EFO_0022680
T2
Human-human somatic cell hybrid cell line, established by PEG-mediated fusion of the B-lymphoblastoid cell line LCL 721.174 with an 8-azaguanine and ouabain-resistant variant of the T-LCL CEM. Subclone of the T1 cell line which has lost both CEM(R)-derived copies of chromosome 6
EFO_0022681
SO-Rb50
Human retinoblastoma cell line
EFO_0022682
Flp-In-T-REx
T-REx cell derivative with targeted integration of a Flp-In expression vector
EFO_0022683
T-REx-HeLa
Human papillomavirus-related cervical adenocarcinoma
EFO_0022684
T/C-28a2
Human chondrocyte cell line
EFO_0022685
PER.C6
transformed human retinoblast cell line
EFO_0022686
HEK293S GnTI-
N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line
EFO_0022687
HuTu-80
Human duodenal adenocarcinoma cell line
EFO_0022688
LAN-5
Human neuroblastoma cell line
EFO_0022689
FU-OV-1
Human ovarian serous adenocarcinoma cell line
EFO_0022690
697
Human acute lymphoblastic leukemia cell line
EFO_0022691
BPH-1
Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens
EFO_0022692
IMR-5
Human neuroblastoma cell line
EFO_0022693
HET-1A
Human esophageal cell line; derived in 1986 from human esophageal autopsy tissue by transfection with plasmid pRSV-T consisting of the RSV-LTR promoter and the sequence encoding the simian virus 40 large T-antigen
EFO_0022694
MOLM-13
Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes
EFO_0022695
U6A
The 2fTGH-U6A Cell Line is part of a panel of IFNy pathway mutant fibrosarcoma cell lines isolated by chemical mutagenesis of IFNy insensitive reporter cells derived from HT1080 cells.
EFO_0022696
HVTs-SM1
Immortalized human vascular smooth muscle cells
EFO_0022697
tsA-201
A transformed human kidney 293 cell line stably expressing an SV40 temperature-sensitive T antigen
EFO_0022698
XPCS2BA
XPCS2BA; also has features of Cockayne syndrome; no evidence of malignancy; bilateral sensorineural hearing loss; dry skin; numerous freckles; hyperpigmented macules; broad-based choreoathetotic gait; brother of GM13025; donor subject is homozygous for a T>C transversion in the ERCC3 gene which results in a phenylalanine-99-to-serine missense mutation [PHE99SER (F99S)].
EFO_0022699
RAO-3
RAO-3 was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (hTERT)
EFO_0022700
EW-7
Human Ewing Sarcoma cell line
EFO_0022701
MCF-7/C4-12
Human invasive breast carcinoma
EFO_0022702
OV-2008
Human cystadenocarcinoma cell line
EFO_0022703
HSC-3
Human oral squamous cell carcinoma cell line
EFO_0022704
NCM-460
Nonmalignant human colonic epithelial cell line
EFO_0022705
U3118MG
Human glioblastoma cell line
EFO_0022706
U3082MG
Human glioblastoma cell line